Adrenal cortical carcinoma in Norway, 1970-1984
- PMID: 1413834
- DOI: 10.1007/BF02067349
Adrenal cortical carcinoma in Norway, 1970-1984
Abstract
Adrenal cortical carcinoma is a rare and highly malignant tumor. This retrospective study includes 99 patients (57 males and 42 females) reported to The Cancer Registry of Norway during the 15 year period from 1970 to 1984. The age adjusted incidence was 1.5 per million per year. Eighty-one patients were diagnosed with adrenal cortical carcinoma when still alive. In 18 cases the diagnosis was first made at autopsy. Median age at diagnosis was 54 years (range 2-88 years) with a slight male predominance. Information about initial symptoms was available in 67 patients, of whom 26 patients (18 females and 8 males) presented with clinically functioning tumors, the Cushing syndrome and virilization being most frequently encountered. Only 28 (35%) of 81 patients diagnosed when still alive had tumors confined to the adrenals. Half of the patients had distant metastases, with lungs and liver being the most frequent sites. Sixty-one patients underwent surgery; 51 patients had a radical or debulking operation and 10 patients had laparotomy with tumor biopsy. After a complete follow-up for at least 6 years (range 6-21 years), only 9 patients were still alive. Early stage (Stage I and II) and curative resection had a significant impact on the outcome of this disease. To improve prognosis, early diagnosis and radical surgery, if feasible, are needed.
Similar articles
-
Adrenocortical carcinoma: epidemiology and natural history.Minerva Endocrinol. 1995 Mar;20(1):89-94. Minerva Endocrinol. 1995. PMID: 7651287 Review.
-
The Italian Registry for Adrenal Cortical Carcinoma: analysis of a multiinstitutional series of 129 patients. The ACC Italian Registry Study Group.Surgery. 1996 Feb;119(2):161-70. doi: 10.1016/s0039-6060(96)80164-4. Surgery. 1996. PMID: 8571201 Clinical Trial.
-
Adrenocortical carcinoma. Our experience.Minerva Endocrinol. 1995 Mar;20(1):95-9. Minerva Endocrinol. 1995. PMID: 7651289 Review.
-
[Adrenal cortical carcinoma: advances in the pathophysiology and management of this malignancy].Bull Acad Natl Med. 2008 Jan;192(1):87-102; discussion 102-3. Bull Acad Natl Med. 2008. PMID: 18663984 Review. French.
-
Italian cancer figures--Report 2015: The burden of rare cancers in Italy.Epidemiol Prev. 2016 Jan-Feb;40(1 Suppl 2):1-120. doi: 10.19191/EP16.1S2.P001.035. Epidemiol Prev. 2016. PMID: 26951748
Cited by
-
Inhibin alpha-subunit (INHA) expression in adrenocortical cancer is linked to genetic and epigenetic INHA promoter variation.PLoS One. 2014 Aug 11;9(8):e104944. doi: 10.1371/journal.pone.0104944. eCollection 2014. PLoS One. 2014. PMID: 25111790 Free PMC article.
-
Case studies in hypertension. Adrenal carcinoma.J Clin Hypertens (Greenwich). 2003 Sep-Oct;5(5):355-8. doi: 10.1111/j.1524-6175.2003.02833.x. J Clin Hypertens (Greenwich). 2003. PMID: 14564138 Free PMC article. No abstract available.
-
Early stage adrenocortical carcinoma-what contributes to poor prognosis after adrenalectomy? A retrospective cohort study.Ann Surg Treat Res. 2024 Oct;107(4):187-194. doi: 10.4174/astr.2024.107.4.187. Epub 2024 Sep 30. Ann Surg Treat Res. 2024. PMID: 39416880 Free PMC article.
-
Adjuvant Therapy in Adrenocortical Carcinoma: Reflections and Future Directions.Cancers (Basel). 2020 Feb 22;12(2):508. doi: 10.3390/cancers12020508. Cancers (Basel). 2020. PMID: 32098326 Free PMC article. Review.
-
Adrenal sarcomatoid carcinoma: a case report and review of the literature.Ulster Med J. 2014 May;83(2):89-92. Ulster Med J. 2014. PMID: 25075137 Free PMC article. Review.